Martin Shkreli's federal trial on securities fraud charges begins this week—and since the former pharmaceutical boss has been dubbed "the most hated man in America," there won't be any shortage of cheerleaders for the prosecution. Shkreli, 34, is accused of illegally taking stock from Retrophin, a biotech company he founded, and using it to pay off investors in a hedge fund he managed after the fund tanked. He is also accused of defrauding those investors. Jury selection begins Monday morning in the case, which isn't directly connected to what Shkreli is best known for: hiking the price of a lifesaving drug by 5,000%. Some background:
- The trial. The trial is expected to last four to six weeks, with dozens of witnesses either supporting or questioning the indictment of Shkreli, reports USA Today, which takes a detailed look at the charges.